Current status:
Cancelled Post Market
Current status date:
2000-06-14
Product name:
SUPRES 250 TAB
DIN:
00231177
Electronic product monograph is not available
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
40:28.20
,
24:08.16
Anatomical Therapeutic Chemical (ATC):
See footnote 4
C02LB01 METHYLDOPA (LEVOROTATORY) AND DIURETICS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
CHLOROTHIAZIDE
|
250 MG
|
METHYLDOPA
|
250 MG
|